18

Feb2014
Last month Manitoba Premier Greg Selinger announced a new Home Cancer Drug Program to cover 100 percent of the costs of oral cancer medications taken outside of CancerCare Manitoba facilities. Prior to the announcement, only cancer medications administered in CancerCare Manitoba facilities were covered. More information on the new ... Read More

18

Feb2014
Last week Manitoba Health Minister Theresa Oswald announced that 120 new drugs would be added to the Manitoba Drug Benefits and Interchangeability Formulary. Among the additions are medicines for stroke prevention, skin cancer and hepatitis C. Full information on the formulary amendments, effective September 24, can be found ... Read More

18

Feb2014
Last week members of the Saskatchewan legislature passed the budget tabled earlier last month, which included a change that would mean 97,000 seniors and 47,000 families pay more for their prescription drugs. The change is an increase in the co-payment cap for the Seniors’ and Children’s Drug Plan ... Read More

18

Feb2014
Saskatchewan Drug Plan (SDP) beneficiaries who travel out of the province for extended periods of time may now be able to receive up-front reimbursement for their prescriptions. Previously, pharmacists were only able to bill for three months worth of prescription costs at a time. The new policy and ... Read More

18

Feb2014
Last week the Government of British Columbia introduced Bill 35, the Pharmaceutical Services Act, to provide supporting legislation for the province’s $1 billion PharmaCare program. This Act will protect the program by law, whereas the program currently relies on government policy. The Act also outlines the framework within which the ... Read More

18

Feb2014
Drug manufacturer submission deadlines for listing on the AHWDBL have been updated.

18

Feb2014
As part of the Alberta Government’s 2013-2014 budget announced last week, a new generic drug pricing rule is effective in the province beginning today. Formerly priced at about 35 percent of the brand price, generic drugs will be 18 percent of the corresponding brand drug price for public ... Read More

18

Feb2014

CDR Update — Issue 98

CDR Update — Issue 98: The final CDR Update of 2013, Issue #98, provides updates on the following: Submission queuing and CDEC Meeting Schedule: CADTH has recently initiated the review of queued Common Drug Review (CDR) submissions on a first-come, first-served basis. As the earliest targeted CDEC meeting date for the recently ... Read More

18

Feb2014
CADTH has completed an environmental scan on Subsequent Entry Biologics (SEB) to support SEB related health care decision-making and policy development in Canada. The report, titled Subsequent Entry Biologics – Emerging Trends in Regulatory Health Technology Assessment Framework, aimed to address three topics concerning SEBs including ... Read More

18

Feb2014
CADTH will begin posting patient input submissions, received on or after February 1, 2014, for drugs reviewed through the Common Drug Review. Earlier this year CADTH invited stakeholder comments and feedback regarding its posting of Patient Input Submissions (CDR Update — Issue 89). After considering the feedback ... Read More